Accretion Nutraveda Stock Price Analysis and Quick Research Report. Is Accretion Nutraveda an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Accretion Nutraveda. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Accretion Nutraveda has a PE ratio of 52.9261804477943 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Accretion Nutraveda has ROA of 33.7114% which is a good sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Accretion Nutraveda has a Current ratio of 2.2387.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Accretion Nutraveda has a ROE of 81.2236%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Accretion Nutraveda has a Debt to Equity ratio of 0.7214 which means that the company has low proportion of debt in its capital.

• Sales growth: Accretion Nutraveda has reported revenue growth of 219.7035% which is fair in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Accretion Nutraveda for the current financial year is 23.2630079116099%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Accretion Nutraveda is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Accretion Nutraveda is Rs 3.6088. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Accretion Nutraveda in Ticker for free. Also, one can get the intrinsic value of Accretion Nutraveda by using Valuation Calculators, which are available with a Finology ONE subscription. 

Accretion Nutraveda FAQs

Q1. What is Accretion Nutraveda share price today?
Ans: The current share price of Accretion Nutraveda is Rs 191.

Q2. What is the market capitalisation of Accretion Nutraveda?
Ans: Accretion Nutraveda has a market capitalisation of Rs 138.284 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Accretion Nutraveda?
Ans: The PE ratio of Accretion Nutraveda is 52.9261804477943 and the P/B ratio of Accretion Nutraveda is 3.89645626482846, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Accretion Nutraveda share?
Ans: The 52-week high share price of Accretion Nutraveda is Rs 200.55, and the 52-week low share price of Accretion Nutraveda is Rs 190.5.

Q5. Does Accretion Nutraveda pay dividends?
Ans: Currently, Accretion Nutraveda does not pay dividends. Dividend yield of Accretion Nutraveda is around 0%.

Q6. What are the face value and book value of Accretion Nutraveda shares?
Ans: The face value of Accretion Nutraveda shares is Rs 10, while the book value per share of Accretion Nutraveda is around Rs 49.0189. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Accretion Nutraveda?
Ans: Accretion Nutraveda has a total debt of Rs 3.8587 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Accretion Nutraveda?
Ans: The ROE of Accretion Nutraveda is 81.2236% and ROCE of Accretion Nutraveda is 56.7227%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Accretion Nutraveda a good buy for the long term?
Ans: The Accretion Nutraveda long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Accretion Nutraveda undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Accretion Nutraveda appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Accretion Nutraveda’s financials?
Ans: You can review Accretion Nutraveda’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.